Michela Croce

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Unveiling the myxofibrosarcoma tumor microenvironment: implications for immunotherapy.

Unveiling the myxofibrosarcoma tumor microenvironment: implications for immunotherapy.

Journal: Frontiers in immunology
Published: October 02, 2025

Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma.

Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma.

Journal: International journal of molecular sciences
Published: July 02, 2025

Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab.

Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab.

Journal: Journal of translational medicine
Published: June 11, 2025

The Systematic Comparison of Enhancer of Zeste Homolog-2-, Bromodomain-containing Proteins-, Histone Deacetylase-, and DNA-methyltransferase 1-inhibitors in a Syngeneic Murine Model of Melanoma Reveals Differential Anti-tumoral and Immunomodulatory Activities.

The Systematic Comparison of Enhancer of Zeste Homolog-2-, Bromodomain-containing Proteins-, Histone Deacetylase-, and DNA-methyltransferase 1-inhibitors in a Syngeneic Murine Model of Melanoma Reveals Differential Anti-tumoral and Immunomodulatory Activities.

Journal: MedComm
Published: December 17, 2024

Machine Learning Methods for Gene Selection in Uveal Melanoma.

Machine Learning Methods for Gene Selection in Uveal Melanoma.

Journal: International journal of molecular sciences
Published: December 27, 2023

Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis.

Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis.

Journal: International journal of molecular sciences
Published: September 28, 2023

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Journal: Cells
Published: January 27, 2023

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 23, 2022

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.

Journal: International journal of molecular sciences
Published: December 20, 2022

Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma.

Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma.

Journal: Cancers
Published: December 19, 2022

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.

Journal: International journal of molecular sciences
Published: November 11, 2022

A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.

A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.

Journal: Cancers
Published: March 24, 2022
Showing 1-12 of 35

Last Updated: 09/26/2026